Overall survival nearly evened out in a clinical trial comparing 2 chemotherapy regimens; adverse events might be a deciding factor in choosing one or the other. br / iMedscape Medical News/i
African-American men are 60 percent more likely develop and die from prostate cancer. Are spiritually based education methods more likely to reach this population? Urologic Nursing
Dr. Bradley A. Patay discusses several important papers reporting on the relationships of multiple genetic markers to prostate cancer. Medscape Pathology
Dr. Kathy Miller discusses with Dr. Jose Baselga and ASCOŽ president Dr. George Sledge 3 important trials looking at therapy for breast cancer in the adjuvant and neoadjuvant settings. Medscape Hematology-Oncology
